Keywords: GlaxoSmithKline, Third quarter 2009 results
GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition
Article | 28 October 2009
UK pharma giant GlaxoSmithKline reports that its third-quarter 2009 attributable profit rose to £1.34 billion ($2.19 billion), up 345 from £1.0 billion in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
